🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Moderna, Inc.

MRNA Healthcare
$49.2 $-0.83 (-1.66%)
Market Cap: $19.51 B
Gurus Holding
5
Popularity Rank
#1754
% of Shares Held
0.19%
Net Activity (Q4 2025)
+$1.22 M

Guru Ownership Trend

Guru Analysis for Moderna, Inc. (MRNA)

Moderna, Inc. (MRNA), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $36.28 M.

Top institutional holders include Renaissance Technologies (RenTech) and Paul Tudor Jones.

Institutional sentiment is currently Bullish. This is evidenced by a $1.22 M net inflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, Ray Dalio reduced exposure by 93.2%.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q4 2025)

+$17.12 M
Total Buy Value
New Buys 2
Additions 0
-$15.89 M
Total Sell Value
Reductions 3
Sold Out 1

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
4
Net Buyers
2

FAQs for Moderna, Inc. (MRNA)

Major holders include Renaissance Technologies (RenTech) ($16.76 M), Paul Tudor Jones ($2.84 M), Jefferies Group ($1.35 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 737,467 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.22 M, with 2 managers increasing positions and 4 managers reducing holdings.

During the most recent reporting period, 3 managers trimmed their positions, while 1 fully exited MRNA. The total reported sell value was $15.89 M.

Yes, 2 managers opened new positions in MRNA, and 0 increased their existing holdings. The total reported buy value was $17.12 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.03% New Buy 568,400 $16.76 M Q4 2025
0.01% Reduce -72.1% 96,206 $2.84 M Q4 2025
0.01% Reduce -52.1% 45,670 $1.35 M Q4 2025
0.00% Reduce -93.2% 15,181 $447,688 Q4 2025
0.00% New Buy 12,010 $354,187 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form